A practical reference on obesity research: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-07-24. Anything still debated is marked as such rather than presented as settled.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form; visual inspection |
| Solubility | Soluble in water and aqueous buffers | Depends on pH, purity, and counterion |
| Typical storage | -20 °C or below, desiccated | Protect from light; avoid repeated freeze-thaw after reconstitution |
| Common analytical method | Reversed-phase HPLC and mass spectrometry | Purity by HPLC; identity and mass by LC-MS or MALDI-TOF |
| Common synonyms | hGH fragment 176–191; AOD-9604 | Names vary in research and product labeling |
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
=== Assay === Fluid dripping from the nose (CSF rhinorrhoea) or ears (CSF otorrhea) should be collected and tested for the protein beta-2 transferrin which would be highly accurate in identifying CS fluid and diagnosing a cranial CSF leak.
===== Activated carbon ===== Activated carbons (ACs) or biological-activated carbon (BAC) are effective adsorbents for a wide variety of contaminants. The adsorptive removal of color, aroma, taste, and other harmful organics and inorganics from drinking water and wastewater is one of their industrial applications. Both a high surface area and a large pore size can improve the efficiency of activated carbon. Activated carbon was utilized by a number of studies to remove heavy metals and other types of contaminants from wastewater. The cost of activated carbon is rising due to a shortage of commercial activated carbon (AC). Because of its high surface area, porosity, and flexibility, activated carbon has a lot of potential in wastewater treatment.
Removal of interfibrillary proteins. Removal of keratin proteins. Collagen swelling due to the alkaline pH. Collagen fibre bundle splitting. Removal of natural grease and fats Liming operations of cattle hides usually last 18 hours and are generally associated with the alkaline phase of beamhouse operations.
When the reagent is methane, the predominant reaction is proton transfer M + CH5+ → (MH)+ + CH4. When the reagent is ammonium, the predominant reaction is proton transfer M + NH4+ → (MH)+ + NH3. When the reagent is isobutane, the reaction may be proton transfer M + (CH3)3C+ → (MH)+ + (CH3)2C=CH2 or adduct formation M + (CH3)3C+ → (M · C(CH3)3)+. CI can also produce negatively charged analyte ions by proton abstraction or adduct formation. For example, ionized NF3 contains F−, which abstracts proton.
The Druze strictly avoid iconography, but use five colors ("Five Limits" خمس حدود khams ḥudūd) as a religious symbol: green, red, yellow, blue, and white. The First limit (green), identified by Ismail at-Tamimi (d. 1030) in the Epistle of the Candle, represents either Hamza Ibn Ali or Jesus, symbolizing the "Universal Mind/Intelligence/Nous".
Sources: en.wikipedia.org
The United States' Center for Drug Evaluation and Research officially recommends that drugs past their expiration date be disposed. It has been argued that this practice is wasteful, since consumers and medical facilities are encouraged to purchase fresh medication to replace their expired products, also resulting in additional profits for pharmaceutical firms.
This prevents BioBricks from being used to create fusion proteins, as the 6bp scar sequence codes for a tyrosine and a stop codon, causing translation to be terminated after the first domain is expressed, while the 8bp scar sequence causes a frameshift, preventing continuous readthrough of the codons. To offer alternative scar sequences that for example give a 6bp scar, or scar sequences that do not contain stop codons, other assembly standards such as the BB-2 Assembly, BglBricks Assembly, Silver Assembly and the Freiburg Assembly were designed. While the easiest method to assemble BioBrick parts is described above, there also exist several other commonly used assembly methods that offer several advantages over the standard assembly. The 3 antibiotic (3A) assembly allows for the correct assembly to be selected via antibiotic selection, while the amplified insert assembly seeks to overcome the low transformation efficiency seen in 3A assembly. The BioBrick assembly standard has also served as inspiration for using other types of endonucleases for DNA assembly. For example, both the iBrick standard and the HomeRun vector assembly standards employ homing endonucleases instead of type II restriction enzymes.
=== Less common === Central nervous system: drowsiness, confusion, lethargy, anxiety, fear, unease, dependence, mood changes, impairment of mental and physical performance Gastrointestinal system: constipation Genitourinary system: inability to urinate, bladder spasms Respiratory depression: decreased rate and effort of breathing Hearing impairment, permanent hearing loss Dermatological: rash, itching
== External links == "Treosulfan". National Cancer Institute. "Treosulfan (Code C1257)". NCI Thesaurus. 25 November 2024. Retrieved 9 March 2025. Clinical trial number NCT00822393 for "Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)" at ClinicalTrials.gov
Sources: en.wikipedia.org
=== Colony forming unit – Hill === As originally isolated by Asahara et al., the CFU-Hill population is an early outgrowth, formed by plating peripheral blood mononuclear cells on fibronectin-coated dishes, allowing adhesion and depleting non-adherent cells, and isolating discrete colonies.
=== Magic numbers === As early as 1914, the possible existence of superheavy elements with atomic numbers well beyond that of uranium—then the heaviest known element—was suggested, when German physicist Richard Swinne proposed that superheavy elements around Z = 108 were a source of radiation in cosmic rays. Although he did not make any definitive observations, he hypothesized in 1931 that transuranium elements around Z = 100 or Z = 108 may be relatively long-lived and possibly exist in nature. In 1955, American physicist John Archibald Wheeler also proposed the existence of these elements; he is credited with the first usage of the term "superheavy element" in a 1958 paper published with Frederick Werner. This idea did not attract wide interest until a decade later, after improvements in the nuclear shell model. In this model, the atomic nucleus is built up in "shells", analogous to electron shells in atoms. Independently of each other, neutrons and protons have energy levels that are normally close together, but after a given shell is filled, it takes substantially more energy to start filling the next. Thus, the binding energy per nucleon reaches a local maximum and nuclei with filled shells are more stable than those without. This theory of a nuclear shell model originates in the 1930s, but it was not until 1949 that German physicists Maria Goeppert Mayer and Johannes Hans Daniel Jensen et al. independently devised the correct formulation. The numbers of nucleons for which shells are filled are called magic numbers.
=== Aging === Telomerase restores short bits of DNA known as telomeres, which are otherwise shortened after repeated division of a cell via mitosis. In normal circumstances, where telomerase is absent, if a cell divides recursively, at some point the progeny reach their Hayflick limit, which is believed to be between 50 and 70 cell divisions. At the limit the cells become senescent and cell division stops. Telomerase allows each offspring to replace the lost bit of DNA, allowing the cell line to divide without ever reaching the limit. This same unbounded growth is a feature of cancerous growth. Embryonic stem cells express telomerase, which allows them to divide repeatedly and form the individual. In adults, telomerase is highly expressed only in cells that need to divide regularly, especially in male sperm cells, but also in epidermal cells, in activated T cell and B cell lymphocytes, as well as in certain adult stem cells, but in the great majority of cases somatic cells do not express telomerase. A comparative biology study of mammalian telomeres indicated that telomere length of some mammalian species correlates inversely, rather than directly, with lifespan, and concluded that the contribution of telomere length to lifespan is unresolved. Telomere shortening does not occur with age in some postmitotic tissues, such as in the rat brain. In humans, skeletal muscle telomere lengths remain stable from ages 23–74.
== Chemistry == DkTx can be purified from the venom of the Chinese bird spider Ornithoctonus huwena using reversed-phase chromatography. DkTx is a cysteine-rich peptide; such peptides are difficult to synthesise because of their low folding efficiency. This is why structural and functional information about these peptides is limited. DkTx is a 75-amino-acid-peptide consisting of two independently folded head-to-tail ICK domains, which are linked together via a seven amino acid long linker peptide. This compact and rigid structure provides the toxin with a high affinity to bind to its target channel. The linker provides the separation of the two knots and allows them to dock to the channel binding sites concomitantly. The two ICK-motifs are referred to as K1 and K2, and each of them consists of six cysteine residues. For this reason, DkTx is part of the ICK peptide family; however its DNA sequence diverges from other ICK peptides, such as the vanillotoxins, huwentoxins or hanatoxin.
On 14 January, the United States Department of Energy announced that the United States had completed their first sales of Venezuelan oil valued at $500 million as part of a $2 billion deal between United States and Venezuela governments. On 15 January, Delcy Rodríguez announced that she was submitting a reform to the country's hydrocarbon law to "allow [foreign] investment flows to be incorporated into new fields, fields where no investment has ever been made and into fields where there is no infrastructure"; On 20 January, Delcy Rodríguez confirmed having received the first $300 million. She announced the money will go to the exchange market in Venezuela, the national banks and the central bank. Reuters indicated that the remaining $200 million were returned on 3 February according to anonymous United States officials. The proceeds from the sales were deposited in a Qatari bank account, preventing Venezuela's creditors from seizing them. Democrats questioned the legality of this arrangement, and criticized the lack of transparency in routing the funds. On 23 January, the first cargo of 460,000 barrels of naphtha by Vitol, necessary to deal with the heavy crude oil, arrived to Venezuela in a deal with the United States. Before that last cargo was received in December 2025 by Chevron Corporation in an agreement with the United States as the naval blockade had stopped many suppliers. On 28 January, Delcy Rodríguez announced that the United States was unfreezing various funds related to 2019 oil sanctions on Venezuela.
Sources: en.wikipedia.org
Lyophilized AOD9604 is generally kept at -20 °C or colder, desiccated, and protected from light. Reconstituted solutions are usually refrigerated and handled to minimize repeated freeze-thaw cycles. These are general laboratory handling practices, not instructions for human use.
Mass spectrometry, such as LC-MS or MALDI-TOF, confirms the molecular mass and can reveal sequence-related impurities. Reversed-phase HPLC is used for purity, and peptide mapping or amino acid analysis can support sequence identity. No single method establishes every quality attribute.
No. AOD9604 is a short synthetic fragment of the hGH sequence, not the full 191-amino-acid hormone. It lacks the regions that mediate hGH receptor activation and growth-promoting effects. Products labeled as AOD9604 should not be assumed to have the same properties as hGH.
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.